Article info
Prognosis
Cohort study
The cardiovascular risk of azithromycin was increased in a large observational cohort study, contradicting findings from prior randomised trials
- Correspondence to
: Dr Joseph Brent Muhlestein
Department of Cardiology, IMC, 5121 S Cottonwood Street, Murray, UT 84107, USA; Brent.Muhlestein{at}imail.org
Citation
The cardiovascular risk of azithromycin was increased in a large observational cohort study, contradicting findings from prior randomised trials
Publication history
- First published September 5, 2012.
Online issue publication
May 15, 2013
Article Versions
- Previous version (5 September 2012).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions